Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GUSB pseudogene 15 (GUSBP15) is classified as a pseudogene in the human genome, located on chromosome 5. It does not encode a functional protein and has no established biological activity, disease association, or role as a therapeutic target. The abbreviation SMA5 is an alternative name, but this gene should not be confused with active gene targets like glucuronidase beta (GUSB). There is no evidence in current biomedical databases or genomic resources to support its use in drug targeting, disease biomarker identification, or mechanism-of-action studies. If your query originated from a database search or literature context that indicates GUSBP15 (SMA5), double-check the spelling and ensure you are not intending to refer to the active GUSB gene, which is an enzyme and a validated therapeutic target. GUSBP15 is strictly a pseudogene with no known function as a receptor, enzyme, transporter, or similar target class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GUSB pseudogene 15 (GUSBP15).